BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15764646)

  • 1. Lysophosphatidylcholine increases endothelial permeability: role of PKCalpha and RhoA cross talk.
    Huang F; Subbaiah PV; Holian O; Zhang J; Johnson A; Gertzberg N; Lum H
    Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L176-85. PubMed ID: 15764646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells.
    Yokoyama K; Ishibashi T; Ohkawara H; Kimura J; Matsuoka I; Sakamoto T; Nagata K; Sugimoto K; Sakurada S; Maruyama Y
    Circulation; 2002 Feb; 105(8):962-7. PubMed ID: 11864926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction.
    Qiao J; Huang F; Lum H
    Am J Physiol Lung Cell Mol Physiol; 2003 Jun; 284(6):L972-80. PubMed ID: 12588708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of protein kinase C isozymes with Rho GTPases.
    Slater SJ; Seiz JL; Stagliano BA; Stubbs CD
    Biochemistry; 2001 Apr; 40(14):4437-45. PubMed ID: 11284700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C-α signals P115RhoGEF phosphorylation and RhoA activation in TNF-α-induced mouse brain microvascular endothelial cell barrier dysfunction.
    Peng J; He F; Zhang C; Deng X; Yin F
    J Neuroinflammation; 2011 Apr; 8():28. PubMed ID: 21473788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability.
    Clements RT; Minnear FL; Singer HA; Keller RS; Vincent PA
    Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L294-306. PubMed ID: 15475381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atrial and brain natriuretic peptides on lysophosphatidylcholine-mediated endothelial dysfunction.
    Murohara T; Kugiyama K; Ota Y; Doi H; Ogata N; Ohgushi M; Yasue H
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):870-8. PubMed ID: 10598132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of tyrosine phosphorylation of PYK2 in vascular endothelial cells by lysophosphatidylcholine.
    Rikitake Y; Kawashima S; Takahashi T; Ueyama T; Ishido S; Inoue N; Hirata K; Yokoyama M
    Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H266-74. PubMed ID: 11406493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
    Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
    J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4.
    Qiao J; Huang F; Naikawadi RP; Kim KS; Said T; Lum H
    Am J Physiol Lung Cell Mol Physiol; 2006 Jul; 291(1):L91-101. PubMed ID: 16461426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin E inhibits lysophosphatidylcholine-induced endothelial dysfunction and platelet activation.
    Murohara T; Ikeda H; Katoh A; Takajo Y; Otsuka Y; Haramaki N; Imaizumi T
    Antioxid Redox Signal; 2002 Oct; 4(5):791-8. PubMed ID: 12470507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases Rac1 and RhoA.
    Varon C; Basoni C; Reuzeau E; Moreau V; Kramer IJ; Génot E
    Exp Cell Res; 2006 Nov; 312(18):3604-19. PubMed ID: 16978608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the Andes Virus Nucleocapsid Protein to RhoGDI Induces the Release and Activation of the Permeability Factor RhoA.
    Gorbunova EE; Mackow ER
    J Virol; 2021 Aug; 95(17):e0039621. PubMed ID: 34133221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells.
    Wojciak-Stothard B; Tsang LY; Haworth SG
    Am J Physiol Lung Cell Mol Physiol; 2005 Apr; 288(4):L749-60. PubMed ID: 15591411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro.
    Schlegel N; Meir M; Spindler V; Germer CT; Waschke J
    J Cell Physiol; 2011 May; 226(5):1196-203. PubMed ID: 20945370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
    Li Z; Liu YH; Xue YX; Liu LB; Wang P
    J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen-gamma C-terminal fragments induce endothelial barrier dysfunction and microvascular leak via integrin-mediated and RhoA-dependent mechanism.
    Guo M; Daines D; Tang J; Shen Q; Perrin RM; Takada Y; Yuan SY; Wu MH
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):394-400. PubMed ID: 19122172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin D2-DP signaling promotes endothelial barrier function via the cAMP/PKA/Tiam1/Rac1 pathway.
    Kobayashi K; Tsubosaka Y; Hori M; Narumiya S; Ozaki H; Murata T
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):565-71. PubMed ID: 23307871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolytic activation of protein kinase Calpha by peroxynitrite in stimulating cytosolic phospholipase A2 in pulmonary endothelium: involvement of a pertussis toxin sensitive protein.
    Chakraborti T; Das S; Chakraborti S
    Biochemistry; 2005 Apr; 44(13):5246-57. PubMed ID: 15794661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory mechanism of ulinastatin: Inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-α via the RhoA/ROCK signal pathway.
    Wei F; Liu S; Luo L; Gu N; Zeng Y; Chen X; Xu S; Zhang D
    Int Immunopharmacol; 2017 May; 46():220-227. PubMed ID: 28329735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.